Boston Scientific Corp. (NYSE: BSX) is 46.27% higher on its value in year-to-date trading and has touched a low of $49.56 and a high of $88.79 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The BSX stock was last observed hovering at around $84.76 in the last trading session, with the day’s loss setting it -0.2%.
Currently trading at $84.56, the stock is -1.76% and 1.09% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.43 million and changing -0.24% at the moment leaves the stock 13.84% off its SMA200. BSX registered 70.76% gain for a year compared to 6-month gain of 17.66%. The firm has a 50-day simple moving average (SMA 50) of $83.6472 and a 200-day simple moving average (SMA200) of $74.279.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 0.91% loss in the last 1 month and extending the period to 3 months gives it a 14.46%, and is -3.92% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.77% over the week and 1.91% over the month.
Boston Scientific Corp. (BSX) has around 48000 employees, a market worth around $124.53B and $15.91B in sales. Current P/E ratio is 69.94 and Fwd P/E is 30.31. Profit margin for the company is 11.26%. Distance from 52-week low is 70.64% and -4.76% from its 52-week high. The company has generated returns on investments over the last 12 months (6.03%).
with sales reaching $4.4B over the same period.The EPS is expected to grow by 20.06% this year, but quarterly earnings will post 16.40% year-over-year. Quarterly sales are estimated to grow 18.00% in year-over-year returns.
Boston Scientific Corp. (BSX) Top Institutional Holders
1920.0 institutions hold shares in Boston Scientific Corp. (BSX), with institutional investors hold 93.20% of the company’s shares. The shares outstanding are 1.47B, and float is at 1.47B with Short Float at 0.77%. Institutions hold 93.02% of the Float.
The top institutional shareholder in the company is FMR LLC with over 141.46 million shares valued at $10.89 billion. The investor’s holdings represent 9.6337% of the BSX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 129.87 million shares valued at $10.0 billion to account for 8.8444 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 126.42 million shares representing 8.6093% and valued at over $9.74 billion, while STATE STREET CORP holds 4.1853 of the shares totaling 61.46 million with a market value of $4.73 billion.
Boston Scientific Corp. (BSX) Insider Activity
The most recent transaction is an insider sale by Mahoney Michael F, the company’s Chairman, President & CEO. SEC filings show that Mahoney Michael F sold 162,777 shares of the company’s common stock on Oct 07 ’24 at a price of $84.63 per share for a total of $13.78 million. Following the sale, the insider now owns 1.57 million shares.
Boston Scientific Corp. disclosed in a document filed with the SEC on Oct 07 ’24 that Fitzgerald Joseph Michael (EVP & Group Pres, Cardiology) sold a total of 132,527 shares of the company’s common stock. The trade occurred on Oct 07 ’24 and was made at $85.00 per share for $11.26 million. Following the transaction, the insider now directly holds 0.16 million shares of the BSX stock.
Still, SEC filings show that on Oct 07 ’24, JOSEPH M FITZGERALD (Officer) Proposed Sale 132,527 shares at an average price of $85.00 for $11.26 million. The insider now directly holds shares of Boston Scientific Corp. (BSX).
